Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Jeanneteau

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Basic Research in Cardiology|August 12, 2011
RISK and SAFE signaling pathway interactions in remote limb ischemic perconditioning in combination with local ischemic postconditioningSophie Tamareille, Victor Mateus, Nehmat Ghaboura, et al.
American Journal of Physiology. Heart and Circulatory Physiology|August 14, 2012
Microparticle release in remote ischemic conditioning mechanismJulien Jeanneteau, Pierre Hibert, Maria Carmen Martinez, et al.
Basic Research in Cardiology|January 11, 2014
The RIPOST-MI study, assessing remote ischemic perconditioning alone or in combination with local ischemic postconditioning in ST-segment elevation myocardial infarctionFabrice Prunier, Denis Angoulvant, Christophe Saint Etienne, et al.
ESC Heart Failure|February 23, 2021
Diagnosis and Treatment of Iron Deficiency in Heart Failure: OFICSel study by the French Heart Failure Working GroupTheo Pezel, Etienne Audureau, Jacques Mansourati, et al.
Archives of Cardiovascular Diseases|October 19, 2024
Clinical outcomes for 2788 patients with transthyretin amyloidosis: Tafamidis meglumine early access program in FranceOlivier Lairez, Patricia Réant, Jocelyn Inamo, et al.
JACC. Advances|November 21, 2025
Characteristics and Prognosis of Wild-Type Transthyretin Amyloid Cardiomyopathy Patients Diagnosed Before 65 Years OldDamien Guijarro, Jean-Christophe Eicher, Mélanie Bézard, et al.
The Canadian Journal of Cardiology|October 31, 2025
Impact of P2Y12 Inhibitors Pretreatment on Stent Thrombosis in Patients Undergoing Percutaneous Coronary Intervention: Insight France PCI RegistryGrégoire Rangé, Guillaume Cayla, Denis Angoulvant, et al.
Orphanet Journal of Rare Diseases|October 30, 2024
Improving genetic testing pathways for transthyretin amyloidosis in France: challenges and strategiesBérénice Hebrard, Marie-Lise Babonneau, Philippe Charron, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 5, 2026
Management and outcomes of patients with ST-segment elevation myocardial infarction and large infarct-related arteriesMarc Bonnet, Loïc Belle, Hugo Pilichowski, et al.
International Journal of Cardiology|June 18, 2025
Impact of Tafamidis on survival in elderly patients: Insights from the Healthcare European Amyloidosis RegistryAntoine Jobbé-Duval, Mounira Kharoubi, Erwan Donal, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Basic Research in Cardiology|August 12, 2011
RISK and SAFE signaling pathway interactions in remote limb ischemic perconditioning in combination with local ischemic postconditioningSophie Tamareille, Victor Mateus, Nehmat Ghaboura, et al.
American Journal of Physiology. Heart and Circulatory Physiology|August 14, 2012
Microparticle release in remote ischemic conditioning mechanismJulien Jeanneteau, Pierre Hibert, Maria Carmen Martinez, et al.
Basic Research in Cardiology|January 11, 2014
The RIPOST-MI study, assessing remote ischemic perconditioning alone or in combination with local ischemic postconditioning in ST-segment elevation myocardial infarctionFabrice Prunier, Denis Angoulvant, Christophe Saint Etienne, et al.
ESC Heart Failure|February 23, 2021
Diagnosis and Treatment of Iron Deficiency in Heart Failure: OFICSel study by the French Heart Failure Working GroupTheo Pezel, Etienne Audureau, Jacques Mansourati, et al.
Archives of Cardiovascular Diseases|October 19, 2024
Clinical outcomes for 2788 patients with transthyretin amyloidosis: Tafamidis meglumine early access program in FranceOlivier Lairez, Patricia Réant, Jocelyn Inamo, et al.
JACC. Advances|November 21, 2025
Characteristics and Prognosis of Wild-Type Transthyretin Amyloid Cardiomyopathy Patients Diagnosed Before 65 Years OldDamien Guijarro, Jean-Christophe Eicher, Mélanie Bézard, et al.
The Canadian Journal of Cardiology|October 31, 2025
Impact of P2Y12 Inhibitors Pretreatment on Stent Thrombosis in Patients Undergoing Percutaneous Coronary Intervention: Insight France PCI RegistryGrégoire Rangé, Guillaume Cayla, Denis Angoulvant, et al.
Orphanet Journal of Rare Diseases|October 30, 2024
Improving genetic testing pathways for transthyretin amyloidosis in France: challenges and strategiesBérénice Hebrard, Marie-Lise Babonneau, Philippe Charron, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 5, 2026
Management and outcomes of patients with ST-segment elevation myocardial infarction and large infarct-related arteriesMarc Bonnet, Loïc Belle, Hugo Pilichowski, et al.
International Journal of Cardiology|June 18, 2025
Impact of Tafamidis on survival in elderly patients: Insights from the Healthcare European Amyloidosis RegistryAntoine Jobbé-Duval, Mounira Kharoubi, Erwan Donal, et al.
Pageof 2